Skip to the page

Data / Form D filings / PHARMATHENE, INC

PHARMATHENE, INC: Form D filings

PHARMATHENE, INC, a company in Annapolis, MD, filed 2 Form D notices with the SEC between 2009 and 2010. The latest, on November 19, 2010, reports $9.9 million sold of a $22.6 million offering to 22 investors.

Find out what PHARMATHENE, INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
ONE PARK PLACE, SUITE 450, Annapolis, MD, 21401
Phone
(410) 269-2600
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506
SEC identifier (CIK)
1326190

The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in other industries: 9,873 rows, $178.73, or the new rows each week for $19.10 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 19, 2010New notice$22,558,299$9,895,186$12,663,11322Nov 3, 2010sec.gov
Aug 12, 2009New notice$19,295,802$19,295,802$022Jul 28, 2009sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Eric I. RichmanExecutive Officer, Director
Steven H. St. PeterDirector
John I. GillDirector
Wayne P. MorgesExecutive Officer
Francesca H. CookExecutive Officer
Joan R. FuscoExecutive Officer
Jordan P. KarpExecutive Officer
James H. CavanaughDirector
Jeffrey W. RungeDirector
Mitchel W. SayareDirector
Joel I. McClearyDirector
Derace L. SchafferDirector
John PappajohnDirector
Thomas R. FuerstExecutive Officer
Valerie A. RiddleExecutive Officer
Charles A. Reinhart IIIExecutive Officer

Other companies in Maryland that filed recently

Every Form D from the week of Nov 15, 2010 · All recent filings in Maryland · All recent Other filings

Read from SEC EDGAR. Amount sold is what PHARMATHENE, INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.